Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil - Lal, Ritu; Sukbuntherng, Juthamas; Luo, Wendy; Tovera, James; Lassauzet, Marie Liesse; Cundy, Kenneth C (Journal of clinical pharmacology, 2013)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Amines - administration & dosage; Amines - adverse effects; Amines - pharmacokinetics; Carbamates - administration & dosage; Carbamates - adverse effects; Carbamates - pharmacokinetics; Cyclohexanecarboxylic Acids - administration & dosage; Cyclohexanecarboxylic Acids - adverse effects; Cyclohexanecarboxylic Acids - pharmacokinetics; Female; gamma-Aminobutyric Acid - administration & dosage; gamma-Aminobutyric Acid - adverse effects; gamma-Aminobutyric Acid - analogs & derivatives; gamma-Aminobutyric Acid - pharmacokinetics; Humans; Male; Middle Aged; Models, Biological; Prodrugs - administration & dosage; Prodrugs - adverse effects; Prodrugs - pharmacokinetics; Restless Legs Syndrome - blood; Restless Legs Syndrome - drug therapy; Sleep Initiation and Maintenance Disorders - blood; Sleep Initiation and Maintenance Disorders - drug therapy; Sleep Initiation and Maintenance Disorders - metabolism; Young Adult